Thrombosis
In pharmacogenetics, understanding thrombosis involves the study of how individual genetic variations can significantly impact the effectiveness of anticoagulant therapies. The focus is on identifying genetic markers that influence clot formation and medication response. This knowledge informs personalized treatment strategies, aiming to improve patient care while minimizing adverse effects like excessive bleeding. It’s an essential area for customizing therapies based on individual genetic makeup for optimal therapeutic outcomes. Goffin’s thrombosis genetic risk panels include the Thrombo StripAssay and related assays for the main inherited thrombophilia factors.
Tell us the target, we’ll find the assay
The catalog shows a slice of our range. If you’re looking for a specific pathogen, sample type or platform fit, our specialists will point you to the right kit, and put together a quote.